Publicacións en colaboración con investigadores/as de Hospital Severo Ochoa (16)

2024

  1. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain

    AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314

  2. Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice

    Blood, Vol. 144, Núm. 6, pp. 646-656

2022

  1. Discovering HIV related information by means of association rules and machine learning

    Scientific Reports, Vol. 12, Núm. 1

  2. High-Risk Obesity Phenotypes: Target for Multimorbidity Prevention at the ROFEMI Study

    Journal of Clinical Medicine, Vol. 11, Núm. 16

  3. Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort

    HIV Medicine, Vol. 23, Núm. 8, pp. 825-836

  4. Registro del Grupo NADYA-SENPE de Nutrición Enteral Domiciliaria en España: años 2018 y 2019

    Nutricion hospitalaria, Vol. 39, Núm. 1, pp. 223-229

2020

  1. Fracture risk assessment in the general population in Spain by FRAX® algorithm. EPISER2016 study

    Medicina Clinica, Vol. 154, Núm. 5, pp. 163-170

  2. Higher prevalence of psoriatic arthritis in the adult population in Spain? A population-based cross-sectional study

    PLoS ONE, Vol. 15, Núm. 6

  3. Predicting clinical outcome with phenotypic clusters in covid-19 pneumonia: An analysis of 12,066 hospitalized patients from the spanish registry semi-covid-19

    Journal of Clinical Medicine, Vol. 9, Núm. 11, pp. 1-19

  4. The prevalence of rheumatoid arthritis in Spain

    Scientific Reports, Vol. 10, Núm. 1

2015

  1. Erratum to "Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project" [Semin Arthritis Rheum 44 (2015) 618-626]

    Seminars in Arthritis and Rheumatism

2013

  1. Clinical applicability and prognostic significance of molecular response assessed by fluorescent-PCR of immunoglobulin genes in multiple myeloma: Results from a GEM/PETHEMA study

    British Journal of Haematology, Vol. 163, Núm. 5, pp. 581-589

2012

  1. Stage IV and age over 45 years are the only prognostic factors of the International Prognostic Score for the outcome of advanced Hodgkin lymphoma in the Spanish Hodgkin Lymphoma Study Group series

    Leukemia and Lymphoma, Vol. 53, Núm. 5, pp. 812-819

2010

  1. Amolecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma

    Blood, Vol. 116, Núm. 8

2009

  1. Large evaluation of anti-cardiolipin and anti-β2 glycoprotein I assays: Results from the Autoimmunity Workshop of the Spanish Society of Immunology

    Inmunologia

  2. Prevalencia de enfermedad arterial periférica asintomática en pacientes con ictus isquémico no cardioembólico

    Neurologia, Vol. 24, Núm. 6, pp. 366-372